VC-backed ChromaDex adds to board of directors

ChromaDex Corp. has named Steve Allen to its board of directors. A former Nestle executive, Allen is currently the non-executive vice-chairman of the LA-based investment firm 6 Pacific Group. Based in Irvine, Calif., ChromaDex, which is backed by DSM Venturing, is a natural products company.


IRVINE, Calif., Jan. 3, 2014 /PRNewswire/ — ChromaDex® Corporation (OTCQB: CDXC) (“ChromaDex” or the “Company”), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today an addition to its board of directors with the appointment of Steve Allen as an independent director.
Allen, age 64, has extensive experience in negotiating merger and acquisition deals and coordinating related due diligence. He has many years of experience handling both in and out-licensing agreements with technology providers and branded companies.
Allen retired from Nestle in December 2009 after a 30-year career in sales, marketing and general management. In 2002, he joined the Mergers and Acquisitions group of Nestle. He was heavily involved in their venture capital investments (Nestle has over $800 million invested in a variety of venture funds) as well as out licensing technologies.
He is currently non-executive Vice-Chairman of 6 Pacific Group (, a Los Angeles based boutique advisory and investment firm, which assists food and beverage companies with capital formation, acquisitions and divestitures. Recently the firm represented New Chapter in the sale to Procter & Gamble — one of the most significant acquisitions in the supplement business in recent years.
Allen co-founded and is a member of the Screening Committee of Nutrition Capital Network (, a business that brings together entrepreneurs and investors in the nutrition and food industries. The major global food and beverage companies (e.g. Coca-Cola, Unilever, General Mills, PepsiCo, Campbell’s, Amway, Hershey’s and Nestle) are cornerstone investors in Nutrition Capital Network and attend the three meetings each year where exciting new investment and partnering opportunities are presented.
Allen is also the Managing Partner of California Agricultural Orchards LLC, which owns almond properties in the Central Valley of California and is President of the Board of the North American Foundation for the University of Leeds ( where he obtained a B.Sc. with Honors.
Commenting on the appointment, Allen stated, “I have known of and followed ChromaDex for years, and am proud to join its Board of Directors. The Company and its management have an excellent reputation within the nutritional supplement industry and the accomplishments in their ingredient technologies business, in such a short time frame, is nothing short of outstanding. I feel my experience, skill sets and industry contacts are very well suited for this appointment. I look forward working with Frank Jaksch and entire ChromaDex team.”
Frank Jaksch, Jr., CEO and co-founder of ChromaDex, commented, “It is with great pride and enthusiasm that I welcome Steve as a ChromaDex director. His tremendous insight and experience in the nutritional industry will be a great asset to both our Board and management team.”
ChromaDex also announced the resignation of Curtis Lockshin from its Board of Directors. The total number of board members remains at nine, of which the majority are independent.
About ChromaDex®:
ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services, and product regulatory and safety consulting (as Spherix Consulting). The company provides seamless science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. The ChromaDex ingredient technologies unit includes products backed with extensive scientific research and intellectual property. Its ingredient portfolio includes pTeroPure® pterostilbene; ProC3G™, a natural black rice containing cyanidin-3-glucoside; PURENERGY™, a caffeine-pTeroPure co-crystal; and NIAGEN™, its recently launched branded nicotinamide riboside, a novel next-generation B vitamin. To learn more about ChromaDex, visit



Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.